您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > NU2058
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
NU2058
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
NU2058图片
CAS NO:161058-83-9
包装与价格:
包装价格(元)
5mg电议
10mg电议
50mg电议
100mg电议

产品介绍
NU2058 (O6-(Cyclohexylmethyl)guanine) 是一种有效的、竞争性的、基于鸟嘌呤的 CDK 抑制剂,对 CDK2 和 CDK1 的 IC50 分别为 17 μM 和 26 μM。 NU2058 具有抗癌活性。
Cas No.161058-83-9
别名O6-(Cyclohexylmethyl)guanine
Canonical SMILESNC1=NC(OCC2CCCCC2)=C3NC=NC3=N1
分子式C12H17N5O
分子量247.3
溶解度DMSO : ≥ 32 mg/mL (129.40 mM)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

NU2058 is a guanine-based CDK inhibitor with IC50 of 17 uM and 26 uM for CDK2 and CDK1.IC50 value: 17uM (CDK2), 26uM (CDK1)Target: CDKin vitro: NU2058 is a competitive inhibitor of CDK2 with respect to ATP (Ki value CDK2, 12 3 uM) that binds in the ATP binding pocket in a different orientation from other purine-based inhibitors, including olomoucine and roscovotine. NU2058 is the lead compound in a structure-based drug discovery program to develop more potent and selective CDK inhibitors.

References:
[1]. Rigas AC, et al. Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer. Oncogene. 2007 Dec 6;26(55):7611-7619.